&nbsp;

OBSP-Screening-Report-Template-with-breast-implants.pdf

Jun 2024

Document

OBSP-Screening-Report-Template-without-breast-implants.pdf

Jun 2024

Symptom Management

Post-Treatment Symptoms – Gynecological Cancer

Document

ONE-ID-CPSO-Registration-Guide-for-New-Users-EN.pdf

Jul 2024

Document

ONE-ID-CPSO-Registration-Guide-for-New-Users-FR.pdf

Jul 2024

Document

ONE-ID-Identity-Access-Management-Service-EN.pdf

Jul 2024

Document

ONE-ID-Identity-Access-Management-Service-FR

Jul 2024

Symptom Management

Symptômes après le traitement – Cancer gynécologique

Regimen

CRBPGEMC+NIVL

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab - Neoadjuvant Treatment for Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2024

Regimen

ABIRNIRPPRED

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

niraparib / abiraterone - For the treatment of metastatic castration resistant prostate cancer in patients with a BRCA mutation

ODB - General Benefit

prednisone

Drugs Used:

niraparib / abiraterone,

prednisone

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

CISPGEMC+PEMB

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2024

Regimen

CRBPGEMC+PEMB

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used: